(Q51115211)

30 March 2018

title

Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly Canadians. (English)

1 reference

30 March 2018

1 reference

4

1 reference

30 March 2018

Lehana Thabane

10

object named as

Lehana Thabane

1 reference

30 March 2018

Janusz Kaczorowski

1

1 reference

30 March 2018

Larry W Chambers

2

1 reference

30 March 2018

Tina Karwalajtys

3

1 reference

30 March 2018

Barbara Farrell

5

1 reference

30 March 2018

Beatrice McDonough

6

1 reference

30 March 2018

Rolf Sebaldt

7

1 reference

30 March 2018

Cheryl Levitt

8

1 reference

30 March 2018

William Hogg

9

1 reference

30 March 2018

Karen Tu

11

1 reference

30 March 2018

Ron Goeree

12

1 reference

30 March 2018

J Michael Paterson

13

1 reference

30 March 2018

Mamdouh Shubair

14

1 reference

30 March 2018

Tracy Gierman

15

1 reference

30 March 2018

Shannon Sullivan

16

1 reference

30 March 2018

Megan Carter

17

1 reference

30 March 2018

language of work or name

English

0 references

publication date

14 February 2008

1 reference

30 March 2018

published in

Preventive Medicine

1 reference

30 March 2018

volume

46

1 reference

30 March 2018

issue

6

1 reference

30 March 2018

page(s)

537-544

1 reference

30 March 2018

A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Methods for the analysis of incidence rates in cluster randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Pharmacist intervention program for control of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

A community-based program for cardiovascular health awareness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Overcoming barriers to effective blood pressure control in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Simple sample size calculation for cluster-randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Awareness, treatment, and control of hypertension in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

A randomized trial of mail vs. telephone invitation to a community-based cardiovascular health awareness program for older family practice patients [ISRCTN61739603]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Community education for cardiovascular disease prevention. Morbidity and mortality results from the Minnesota Heart Health Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Reconsidering Community-Based Health Promotion: Promise, Performance, and Potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Diet and exercise habits of patients with diabetes, dyslipidemia, cardiovascular disease or hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Prevalence, treatment, and control of hypertension in primary care: gaps, trends, and opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Mortality impact of an integrated community cardiovascular health program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Recruiting family physicians and patients for a clinical trial: lessons learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Methodologic advances and ongoing challenges in designing community-based health promotion programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Validating administrative data in stroke research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Hypertension guidelines in elderly patients: is anybody listening?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.005

10.1016/J.YPMED.2008.02.005

7 January 2021

Identifiers

DOI

1 reference

30 March 2018

PubMed ID

18372036

1 reference

30 March 2018